Stockreport

Ocular Therapeutix: Focus On Axpaxli's Path To Market In Wet-AMD And Implications To Investors [Seeking Alpha]

Ocular Therapeutix, Inc.  (OCUL) 
Last ocular therapeutix, inc. earnings: 3/12 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ocutx.com
PDF 28min Summary In my previous article, I rated Ocular as a “Hold” based on concerns regarding Axpaxli's path to market. The SOL-1 and SOL-R Phase III trials are de [Read more]